We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Sunday
May 17
15:15 - 16:15
T2
Lung cancer 2
Gerard Walls, United Kingdom;
Rafal Dziadziuszko, Poland
Mini-Orals
Clinical
15:15 - 16:15
A prospective trial of same-day sim-plan-and-treat single fraction SABR for early lung cancer (One-Stop SABR; ACTRN12624001431516).
Neil Wallace, Australia
-3883
15:15 - 16:15
Upfront palliative radiotherapy prior to chemoimmunotherapy in metastatic non-small lung cancer - a prospective, phase II study PRIMM (NCT 05440916)
Jasna But Hadzic, Slovenia
-1782
15:15 - 16:15
Sparing immune rich organs spare the expanding Ki-67+CD8+ and Ki-67+CD4+ T-cell fractions during lung SBRT- randomized clinical trial (NCT04273893)
Krishni Wijesooriya, USA
-5027
15:15 - 16:15
Dedalus trial: update of sequential chemo-RT-durvalumab, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen
Jessica Saddi, Italy
-2625
15:15 - 16:15
STereotActic Radiotherapy in LOcally advanced non-small cell lung cancer unfit for concurRent chemoraDiation:preliminary results of the STARLORD study
Francesco Cuccia, Italy
-2305
15:15 - 16:15
Radiographic Response in Patients with Stage III Unresectable Non-Small Cell Lung Cancer Treated with an Intratumoral Radioenhancer (JNJ-90301900)
Jeffrey Bradley, USA
-116
15:15 - 16:15
Real-world outcomes of prophylactic cranial irradiation in patients with limited disease small cell lung cancer in a Scandinavian patient cohort
Sara Linde, Denmark
-2117
15:15 - 16:15
No PCI, No Escape: MRI Surveillance Reveals Silent Brain Metastases in SCLC – A Multicenter Cohort
Ismaell Massalha, Israel
-3235